We are looking for children 2–17 years old to join a medical research study to help us discover more about treating moderately to severely active ulcerative colitis. If you are looking for a potential new treatment option for moderately to severely active ulcerative colitis or moderately to severely active ulcerative colitis (including associated symptoms such as rectal bleeding, abdominal cramps, diarrhea, weight loss and/or anemia), consider one of our CD and UC studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the CD and UC studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

We are looking for young people aged 2 to 17 years to join a Crohn’s disease (CD) research study to help us discover more about treating Crohn’s disease. If you are looking for a potential new treatment option for Crohn’s disease or CD (including associated symptoms such as weight loss, fatigue, cramps, chronic fatigue and/or joint pain), consider one of our trials. All eligible participants will receive no-cost study-related care and study medication. Your young people aged 2 to 17 years may be eligible to take part.

Your child may be eligible to take part in the trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited so act quickly.

We are looking for child to join a Crohn’s disease trial to help us discover more about treating moderate to severe IBD. If you are looking for a potential new treatment option for moderate to severe IBD or Crohn’s (including associated symptoms such as urgency to defecate, mouth sores, diarrhea, malnutrition and/or joint pain), consider one of our research. All eligible participants will receive no-cost study-related care and study medication. Your child may be eligible to take part.

Your child may be eligible to take part in the research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to take part.

Is your child currently experiencing moderate to severe Crohn’s disease flare-ups? Local CD clinical research is testing a potential new medication to see if it may reduce painful joints, reduced appetite, bloody stool, chronic fatigue, and/or liver disease associated with moderate to severe Crohn’s disease.
If you’re concerned about how moderate to severe Crohn’s disease affects your child’s life, find out more about the CD clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.

We are looking for young people aged 2 to 17 years to join a CD research to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or moderate to severe IBD (including associated symptoms such as long-term diarrhea, growth failure, bloody stool, malnutrition and/or eye pain), consider one of our IBD research studies. All eligible participants will receive no-cost study-related care and study medication. Your young people aged 2 to 17 years may be eligible to take part.

Your child may be eligible to take part in the IBD research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrolling for a limited time.

Is your child currently experiencing CD flare-ups? Local Crohn’s disease trial is testing a potential new medication to see if it may reduce long-term diarrhea, weight loss, rectal pain, chronic fatigue, and/or anemia associated with CD.
If you’re concerned about how CD affects your child’s life, find out more about the Crohn’s disease trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

Is your child currently experiencing moderate to severe Crohn’s disease flare-ups? Local trial is testing a potential new medication to see if it may reduce diarrhea with blood, abdominal cramps, cramps, malnutrition, and/or anemia associated with moderate to severe Crohn’s disease.
If you’re concerned about how moderate to severe Crohn’s disease affects your child’s life, find out more about the trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

Is your child currently experiencing Crohn’s disease flare-ups? Local Crohn’s disease clinical trial is testing a potential new medication to see if it may reduce stomach pain, blood in the stool, abdominal pain, malnutrition, and/or anemia associated with Crohn’s disease.
If you’re concerned about how Crohn’s disease affects your child’s life, find out more about the Crohn’s disease clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Act now.

We are looking for child to join a Crohn’s disease research to help us discover more about treating CD. If you are looking for a potential new treatment option for CD or Crohn’s (including associated symptoms such as cramps, inflammation of the bowel or intestine, cramps, weight loss and/or canker sores), consider one of our clinical research. All eligible participants will receive no-cost study-related care and study medication. Your child may be eligible to take part.

Your child may be eligible to take part in the clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

We are looking for children aged 2 to 17 years to join a Crohn’s disease (CD) study to help us discover more about treating ulcerative colitis. If you are looking for a potential new treatment option for ulcerative colitis or moderate to severe IBD (including associated symptoms such as diarrhea with pus, reduced appetite, constant need to poop, weight loss and/or joint pain), consider one of our Crohn’s disease (CD) clinical research. All eligible participants will receive no-cost study-related care and study medication. Your children aged 2 to 17 years may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease (CD) clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child is eligible.